Natural activators of autophagy were reported to exert beneficial effects in preclinical models of cardiovascular diseases, acting on specific molecular targets such as the mechanistic target of rapamycin complex 1 (mTORC1), transcription factor EB (TFEB), and 5′ adenosine monophosphate-activated protein kinase [11,12]. The gene discussed is TFEB; the disease is cardiovascular disorder.